MTOR and hepatocellular carcinoma: Using a combination of bioinformatic analyses and experimental approaches based on cell culture and xenograft models, they demonstrated that PSMD12 promotes HCC progression by influencing the G2/M phase of the cell cycle and modulating the PI3K/AKT/mTOR signaling pathway.